These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [The incidence of hepatitis B antigen subtypes in acute hepatitis and chronic liver diseases]. Büki B, Szalay F, Nagylucskay S, Schvaáb E. Orv Hetil; 1975 Jul 06; 116(27):1567-9. PubMed ID: 1143846 [No Abstract] [Full Text] [Related]
3. [Leukocyte migration test in liver diseases]. Vergani C, Oldoni T, Dioguardi N. Minerva Med; 1974 Apr 15; 65(31):1701-16. PubMed ID: 4599655 [No Abstract] [Full Text] [Related]
4. Subtypes of Australia antigen among patients and healthy carriers in Copenhagen. A relation between the subtypes and the degree of liver damage in acute viral hepatitis. Nielsen JO, Le Bouvier GL. N Engl J Med; 1973 Jun 14; 288(24):1257-61. PubMed ID: 4703314 [No Abstract] [Full Text] [Related]
5. [Clinical significance of hepatitis B-antigen]. Kaboth U. Internist (Berl); 1973 Nov 14; 14(11):554-63. PubMed ID: 4272695 [No Abstract] [Full Text] [Related]
6. [Australia-(hepatitis-B-) antigen. Properties and clinical significance]. Sauerbruch T. Med Klin; 1974 Dec 20; 69(51-52):2106-15. PubMed ID: 4216755 [No Abstract] [Full Text] [Related]
7. [Behavior and importance of immunoglobulins in acute and chronic hepatitis]. Schumacher K, Maerker-Alzer G. Internist (Berl); 1973 Nov 20; 14(11):578-82. PubMed ID: 4590128 [No Abstract] [Full Text] [Related]
8. [Radioimmunoquantization of the HBAg in clinical liver diseases]. De Ritis F, Gravina E, Squame G, Celentano L. Quad Sclavo Diagn; 1975 Jun 20; 11(2):446-62. PubMed ID: 1223948 [Abstract] [Full Text] [Related]
9. [Immunological problems in chronic liver diseases]. Bartók I. Orv Hetil; 1973 Aug 19; 114(33):1971-5. PubMed ID: 4728404 [No Abstract] [Full Text] [Related]
10. [The significance of Australia antigen (HAA) determination for the clinical picture of hepatitis]. Reinhardt M, Schmitz J, Jorke D. Dtsch Z Verdau Stoffwechselkr; 1973 Aug 19; 33(2):57-78. PubMed ID: 4596686 [No Abstract] [Full Text] [Related]
12. Circulating conversion products of C3 in liver disease. Evidence for in vivo activation of the complement system. Teisberg P, Gjone E. Clin Exp Immunol; 1973 Aug 19; 14(4):509-14. PubMed ID: 4201114 [Abstract] [Full Text] [Related]
13. [Incidence of Australia antigen in patients with acute virus hepatitis and chronic hepatic disorders following virus hepatitis in our records]. Patorska-Mach E, Pieciński Z, Siuciak J. Pol Tyg Lek; 1972 Dec 11; 27(50):1975-7. PubMed ID: 4649227 [No Abstract] [Full Text] [Related]
15. [Detection of Australia antigen and corresponding antibodies during different diseases of the liver. Comparison of the technics used]. Lavillaureix L, Cvoric M, Lautier F, Stahl J. Nouv Presse Med; 1973 Mar 03; 2(9):580. PubMed ID: 4634051 [No Abstract] [Full Text] [Related]
17. Relation of protraction of acute viral hepatitis to Australia antigen. Kamada T, Akeyama T, Noyama T, Abe H. Acta Hepatogastroenterol (Stuttg); 1974 Oct 03; 21(5):358-63. PubMed ID: 4450991 [No Abstract] [Full Text] [Related]
18. [Australia antigen and its relationship to viral hepatitis (a review of the literature)]. Golosova TV, Margolina AN. Lab Delo; 1973 Oct 03; 6():323-7. PubMed ID: 4129381 [No Abstract] [Full Text] [Related]
19. Incidence and meaning of persistence of Australia antigen in patients with acute viral hepatitis: development of chronic hepatitis. Nielsen JO, Dietrichson O, Elling P, Christoffersen P. N Engl J Med; 1971 Nov 18; 285(21):1157-60. PubMed ID: 5096636 [No Abstract] [Full Text] [Related]
20. [Botkin's viral hepatitis and the problem of the Australia antigen]. Barinskiĭ IF, Shubladze AK. Sov Med; 1973 May 18; 36(5):36-42. PubMed ID: 4358526 [No Abstract] [Full Text] [Related] Page: [Next] [New Search]